FDA Inspectors Focusing Attention On Traditional Manual Aseptic Filling Lines
Executive Summary
Firms that manufacture sterile drugs on traditional filling lines instead of using restricted access barriers or isolators risk tighter scrutiny from FDA inspectors, agency official says. Yet it remains unclear how much of a difference the increased oversight will make.